Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Rotavirus Vaccine 116E in Infants
NCT00439660Phase 2Completed
- Sponsor
- Bharat Biotech
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Bharat Biotech. Started Dec 2006; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00439660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439660.